Mansourian, M., Badiee, A., Jalali, S., Shariat, S., Yazdani, M., Amin, M., & Jaafari, M. (2014). Effective induction of anti-tumor immunity using p5 HER-2/neu derived peptide encapsulated in fusogenic DOTAP cationic liposomes co-administrated with CpG-ODN. Immunology Letters, 162(1 Pt A), 87-93. https://doi.org/10.1016/j.imlet.2014.07.008 (Original work published 2014)
Breast cancer
Shariat, S., Badiee, A., Jalali, S., Mansourian, M., Yazdani, M., Mortazavi, S., & Jaafari, M. (2014). P5 HER2/neu-derived peptide conjugated to liposomes containing MPL adjuvant as an effective prophylactic vaccine formulation for breast cancer. Cancer Letters, 355(1), 54-60. https://doi.org/10.1016/j.canlet.2014.09.016 (Original work published 2014)
Shariat, S., Badiee, A., Jalali, S., Mansourian, M., Mortazavi, S., & Jaafari, M. (2015). Preparation and characterization of different liposomal formulations containing P5 HER2/neu-derived peptide and evaluation of their immunological responses and antitumor effects. Iranian Journal of Basic Medical Sciences, 18(5), 506-13. (Original work published 2015)
Arab, A., Behravan, J., Razazan, A., Gholizadeh, Z., Nikpoor, A., Barati, N., … Jaafari, M. (2018). A nano-liposome vaccine carrying E75, a HER-2/neu-derived peptide, exhibits significant antitumour activity in mice. Journal of Drug Targeting, 26(4), 365-372. https://doi.org/10.1080/1061186X.2017.1387788 (Original work published 2018)